Candid Therapeutics

This early-stage study tests a new drug called CND261 in 47 adults with moderate-to-severe rheumatoid arthritis who haven't responded well to other treatments. The main goal is to check the drug's safety and how the body handles it. Researchers will also look for signs that the d…

This study looks at how much of the drug cizutamig gets into the blood when given as a shot under the skin compared to into a vein. It involves 24 healthy adults aged 18 to 65. The goal is to understand the drug's absorption, not to treat any disease.